US Stock MarketDetailed Quotes

TCRX TScan Therapeutics

Watchlist
  • 2.910
  • +0.010+0.34%
Trading Dec 19 13:31 ET
155.31MMarket Cap-3.06P/E (TTM)

TScan Therapeutics Key Stats

TScan Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2025/Q1 -- / 1.381M --
-- 2024/Q4 -- / 1.510M --
-- 2024/Q3 1.049M / 1.173M --
-- 2024/Q2 536.000K / 1.819M --
-- 2024/Q1 566.000K / 4.300M --
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 1.381M--
--2024/Q4-- / 1.510M--
--2024/Q31.049M / 1.173M--
--2024/Q2536.000K / 1.819M--
--2024/Q1566.000K / 4.300M--

Unlock Free Earnings Estimates

TScan Therapeutics Earnings Reports

Read more

Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Dec 5, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data